Title:
Temperature dependent polymorphism of pyrazinamide: An in situ Raman and DFT study

dc.contributor.authorPoornima Sharma
dc.contributor.authorRajib Nandi
dc.contributor.authorDebraj Gangopadhyay
dc.contributor.authorAnurag Singh
dc.contributor.authorRanjan K. Singh
dc.date.accessioned2026-02-07T08:47:49Z
dc.date.issued2018
dc.description.abstractThe α and γ polymorphs of drug pyrazinamide have been detected with the help of temperature dependent Raman spectroscopic technique. Pyrazinamide is a very useful drug used for the treatment of tuberculosis (TB) and plays a significant role in destroying the dormant tubercle bacilli which are not destroyed by other common TB drugs. Temperature dependent Raman spectra suggest polymorphic phase change from α → γ form of pyrazinamide between 145 and 146 °C. In situ Raman spectra of pyrazinamide between 145 and 146 °C show the conversion of α → γ form by the shift in C[dbnd]O stretching vibration accompanied by several other changes. The phase change is characterized by the breaking of two linear N[sbnd]H ⋯ O type hydrogen bonds associated with C[dbnd]O stretching vibration in α dimer and formation of one linear N[sbnd]H ⋯ N type hydrogen bond along with a weak intramolecular C[sbnd]H ⋯ O type hydrogen bond in the γ dimer. © 2017
dc.identifier.doi10.1016/j.saa.2017.09.016
dc.identifier.issn13861425
dc.identifier.urihttps://doi.org/10.1016/j.saa.2017.09.016
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/32577
dc.publisherElsevier B.V.
dc.subjectDFT
dc.subjectHydrogen bonding
dc.subjectPyrazinamide
dc.subjectRaman spectroscopy
dc.subjectTuberculosis
dc.titleTemperature dependent polymorphism of pyrazinamide: An in situ Raman and DFT study
dc.typePublication
dspace.entity.typeArticle

Files

Collections